Stay updated with breaking news from Fran Visco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“I’ve been reminded that you don’t know how long you have," Dr. Love said after her own diagnosis. "We have to get rid of this disease, and there is no reason we can’t do it.”
'Compelling and landmark' results will ‘fundamentally change’ the journey of patients with stage 2 and 3 early breast cancer, specifically those in need of new, well-tolerated options to prevent their cancer from coming back.
'Compelling and landmark' results will ‘fundamentally change’ the journey of patients with stage 2 and 3 early breast cancer, specifically those in need of new, well-tolerated options to prevent their cancer from coming back.
Even when the disease is caught early, breast cancer recurrence is relatively commonplace -- and for survivors, the prospect can be daunting. A drug developed by Swiss pharmaceutical maker Novartis has now been shown to reduce this risk by a quarter in a large group of early-stage survivors, offering patients…
Washington: Even when the disease is caught early, breast cancer recurrence is relatively commonplace and for survivors, the prospect can be daunti...